Danish pharmaceutical group buys US company in move to expand lung-cancer drug worldwide
The Danish pharmaceutical group Pharmacosmos today announced that it has acquired the American listed company G1 Therapeutics. The total equity value of the acquisition is DKK 2.8 billion, or USD 405 million, according to a press release from G1. The Danish company, via its US subsidiary Pharmacosmos Therapeutics Inc., will acquire all outstanding shares of […]
Full version of this article is only available to subscribers.
Already a subscriber, sign in here:
Gain unlimited access to all of The Copenhagen Post
Our independent reporting can only be published with support from our readers.
Monthly subscription
119
DKK/month.
(Billed once a month)
Give us a try
6 month subscription
99
DKK/month.
(Billed twice a year)
Yearly subscription
79
DKK/month.
(Billed once a year)
The post Danish pharmaceutical group buys US company in move to expand lung-cancer drug worldwide appeared first on The Copenhagen Post.